122 related articles for article (PubMed ID: 38065805)
1. Patient-reported prostate cancer treatment regret following primary partial gland cryoablation.
Lepor H; Rapoport E; Gogaj R; Hernandez H; Wysock JS
Urol Oncol; 2024 Jan; 42(1):20.e1-20.e7. PubMed ID: 38065805
[TBL] [Abstract][Full Text] [Related]
2. Oncological and Functional Outcomes of Patients Undergoing Individualized Partial Gland Cryoablation of the Prostate: A Single-Institution Experience.
Tan WP; Chang A; Sze C; Polascik TJ
J Endourol; 2021 Sep; 35(9):1290-1299. PubMed ID: 33559527
[No Abstract] [Full Text] [Related]
3. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
[TBL] [Abstract][Full Text] [Related]
4. Oncological and functional outcomes of men undergoing primary whole gland cryoablation of the prostate: A 20-year experience.
Tan WP; Kotamarti S; Chen E; Mahle R; Arcot R; Chang A; Ayala A; Michael Z; Seguier D; Polascik TJ
Cancer; 2022 Nov; 128(21):3824-3830. PubMed ID: 36107496
[TBL] [Abstract][Full Text] [Related]
5. Comparisons of Oncological and Functional Outcomes Between Primary Whole-Gland Cryoablation and High-Intensity Focused Ultrasound for Localized Prostate Cancer.
Liu YY; Chiang PH
Ann Surg Oncol; 2016 Jan; 23(1):328-34. PubMed ID: 26088651
[TBL] [Abstract][Full Text] [Related]
6. The Effects of Focal Therapy for Prostate Cancer on Sexual Function: A Combined Analysis of Three Prospective Trials.
Yap T; Ahmed HU; Hindley RG; Guillaumier S; McCartan N; Dickinson L; Emberton M; Minhas S
Eur Urol; 2016 May; 69(5):844-51. PubMed ID: 26525837
[TBL] [Abstract][Full Text] [Related]
7. Oncological and Functional Outcomes for Men Undergoing Salvage Whole-gland Cryoablation for Radiation-resistant Prostate Cancer.
Tan WP; Kotamarti S; Ayala A; Mahle R; Chen E; Arcot R; Chang A; Michael Z; Seguier D; Polascik TJ
Eur Urol Oncol; 2023 Jun; 6(3):289-294. PubMed ID: 36890104
[TBL] [Abstract][Full Text] [Related]
8. Association of Treatment Modality, Functional Outcomes, and Baseline Characteristics With Treatment-Related Regret Among Men With Localized Prostate Cancer.
Wallis CJD; Zhao Z; Huang LC; Penson DF; Koyama T; Kaplan SH; Greenfield S; Luckenbaugh AN; Klaassen Z; Conwill R; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg MR; Hashibe M; O'Neil BB; Hoffman KE; Barocas DA
JAMA Oncol; 2022 Jan; 8(1):50-59. PubMed ID: 34792527
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of erectile management techniques to men scheduled for radical prostatectomy reduces long-term regret: a comparative cohort study.
Kinsella J; Acher P; Ashfield A; Chatterton K; Dasgupta P; Cahill D; Popert R; O'Brien T
BJU Int; 2012 Jan; 109(2):254-8. PubMed ID: 21883815
[TBL] [Abstract][Full Text] [Related]
10. Salvage Prostate Cryoablation for the Management of Local Recurrence After Primary Cryotherapy: A Retrospective Analysis of Functional and Intermediate-Term Oncological Outcomes Associated With a Second Therapeutic Freeze.
Aminsharifi A; Jibara G; Tsivian E; Tsivian M; Elshafei A; Polascik TJ
Clin Genitourin Cancer; 2019 Aug; 17(4):e831-e836. PubMed ID: 31213413
[TBL] [Abstract][Full Text] [Related]
11. Biopsy Assessment of Oncologic Control 3 Years Following Primary Partial Gland Cryoablation: A Prospective Cohort Study of Men With Intermediate-risk Prostate Cancer.
Wysock JS; Rapoport E; Hernandez H; Gogaj R; Lepor H
J Urol; 2023 Sep; 210(3):454-464. PubMed ID: 37285232
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Outcomes Between Preoperatively Potent Men Treated with Focal Versus Whole Gland Cryotherapy in a Matched Population.
Mendez MH; Passoni NM; Pow-Sang J; Jones JS; Polascik TJ
J Endourol; 2015 Oct; 29(10):1193-8. PubMed ID: 26058496
[TBL] [Abstract][Full Text] [Related]
13. Anterior gland focal cryoablation: proof-of-concept primary prostate cancer treatment in select men with localized anterior cancers detected by multi-parametric magnetic resonance imaging.
Sze C; Tsivian E; Tay KJ; Schulman AA; Davis LG; Gupta RT; Polascik TJ
BMC Urol; 2019 Dec; 19(1):127. PubMed ID: 31805908
[TBL] [Abstract][Full Text] [Related]
14. Cryoablation as primary treatment for localized prostate cancer followed by penile rehabilitation.
Ellis DS; Manny TB; Rewcastle JC
Urology; 2007 Feb; 69(2):306-10. PubMed ID: 17320669
[TBL] [Abstract][Full Text] [Related]
15. Associations Between Prostate Volume and Oncologic Outcomes in Men Undergoing Focal Cryoablation of the Prostate.
Elshafei A; Tay KJ; Kara O; Malkoc E; Nyame Y; Arora H; Hatem A; Patel SA; Lugnani F; Polascik TJ; Jones JS
Clin Genitourin Cancer; 2018 Apr; 16(2):e477-e482. PubMed ID: 29174470
[TBL] [Abstract][Full Text] [Related]
16. Focal prostate cryoablation: initial results show cancer control and potency preservation.
Bahn DK; Silverman P; Lee F; Badalament R; Bahn ED; Rewcastle JC
J Endourol; 2006 Sep; 20(9):688-92. PubMed ID: 16999628
[TBL] [Abstract][Full Text] [Related]
17. On-demand use of erectile aids in men with preoperative erectile dysfunction treated by whole gland prostate cryoablation.
Kimura M; Donatucci CF; Tsivian M; Caso JR; Moreira DM; Mouraviev V; Satoh T; Baba S; Polascik TJ
Int J Impot Res; 2011; 23(2):49-55. PubMed ID: 21368768
[TBL] [Abstract][Full Text] [Related]
18. Does prior surgical interventional therapy for BPH affect the oncological or functional outcomes after primary whole-gland prostate cryoablation for localized prostate cancer?
ElShafei A; DeWitt-Foy M; Calaway A; Fernstrum AJ; Hijaz A; Muncey W; Alfahmy A; Mahran A; Mishra K; Stephen Jones J; Polascik TJ
Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):507-513. PubMed ID: 33483626
[TBL] [Abstract][Full Text] [Related]
19. Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy.
de Castro Abreu AL; Bahn D; Leslie S; Shoji S; Silverman P; Desai MM; Gill IS; Ukimura O
BJU Int; 2013 Aug; 112(3):298-307. PubMed ID: 23826840
[TBL] [Abstract][Full Text] [Related]
20. Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement.
Deivasigamani S; Kotamarti S; Rastinehad AR; Salas RS; de la Rosette JJMCH; Lepor H; Pinto P; Ahmed HU; Gill I; Klotz L; Taneja SS; Emberton M; Lawrentschuk N; Wysock J; Feller JF; Crouzet S; Kumar M P; Seguier D; Adams ES; Michael Z; Abreu A; Jack Tay K; Ward JF; Shinohara K; Katz AE; Villers A; Chin JL; Stricker PD; Baco E; Macek P; Ahmad AE; Chiu PKF; Crawford ED; Rogers CG; Futterer JJ; Rais-Bahrami S; Robertson CN; Hadaschik B; Marra G; Valerio M; Chong KT; Kasivisvanathan V; Tan WP; Lomas D; Walz J; Guimaraes GC; Mertziotis NI; Becher E; Finelli A; Kasraeian A; Lebastchi AH; Vora A; Rosen MA; Bakir B; Arcot R; Yee S; Netsch C; Meng X; de Reijke TM; Tan YG; Regusci S; Benjamin TGR; Olivares R; Noureldin M; Bianco FJ; Sivaraman A; Kim FJ; Given RW; Dason S; Sheetz TJ; Shoji S; Schulman A; Royce P; Shah TT; Scionti S; Salomon G; Laguna P; Tourinho-Barbosa R; Aminsharifi A; Cathelineau X; Gontero P; Stabile A; Grummet J; Ledbetter L; Graton M; Stephen Jones J; Polascik TJ;
Eur Urol; 2023 Dec; 84(6):547-560. PubMed ID: 37419773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
